You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
You need to be a full subscriber to access this feature of the Switzer Super Report. Click here to upgrade your subscription or read recently answered questions below
James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian.
His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007...View more >
While it has been a typical reporting season, there is a group of stocks where results were surprisingly good, but the market still appears to be under-valuing them. Here are three representatives fro..
The mining heavyweights have been a lucrative source of fully franked dividends and while last week was something of a shock for investors who rely on the dividend flow from the big miners, they do st..
It made a massive splash last week, but is Sigma Healthcare worth buying?
The price of gold surged 34% last year and is already 9% higher this year, having notched a fresh record high of US$2,866.20 an ounce last month, making this a wonderful operating environment for gold..
Is there value in the S&P/ASX 20 right now? Here’s a look at four ‘buy’ prospects from the ASX’s top echelon: Telstra, Rio Tinto, BHP and CSL.
Here are two Australian medical device companies doing impressive things in the medical imaging area in Australia and the US.
